A novel optimal medical therapy for preventing secondary cardiovascular events in subjects with coronary artery diseases in Japan.

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Tabito Kino

University of Tsukuba, Tsukuba (Japan)

32 More presentations in this session

Presentation thumbnail

Impact of comorbidities on major adverse events in atrial fibrillation: 3 years follow-up of the EORP-AF general pilot registry

Associate Professor M. Proietti (Milan, IT)

Abstract Slides

Presentation thumbnail

ABC-death risk score predicts mortality better than CHA2DS2-VASc score in a contemporary population of hospitalised patients with atrial fibrillation

Professor G. Giannakoulas (Thessaloniki, GR)

Abstract Slides

Presentation thumbnail

Intima-Media thickness to better risk-stratify patients with premature coronary artery disease: an analysis from the AFUI registry.

Associate Professor M. Zeitouni (Paris, FR)

Abstract Slides

Presentation thumbnail

Prognostic value of elevated electromagnetic QRS-fragmentation index on 5-year outcome in patients with acute myocardial infarction undergoing cardiac magnet field imaging

Mr O. Mohammad (Ludwigshafen, DE)

Presentation thumbnail

The prognostic importance of pulmonary pressure increase in early cardiovascular diseases

Doctor P. Giovanardi (Modena, IT)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 7 - Secondary prevention

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Making personalised prevention everyone's business

Congress Presentation

Should we intervene early in patients with asymptomatic aortic stenosis?

Congress Presentation

Cardiovascular prevention in older adults

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources